Low
₹61,811.70
High
₹62,152.15
Low
₹52,032.85
High
₹62,907.50
| Previous Close | ₹61,802.05 |
|---|---|
| Day's Range | ₹61,811.70 - ₹62,152.15 |
| Open | ₹61,960.75 |
| 52 Week Range | ₹52,032.85 - ₹62,907.50 |
| Volume | 1,43,86,19,105 |
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Blue Star Ltd. | 1695.60 | |
Consumer Durables |
| Exide Industries Ltd. | 388.40 | |
Automobile & Ancillaries |
| Dabur India Ltd. | 429.00 | |
FMCG |
| Bharat Heavy Electricals Ltd. | 392.25 | |
Capital Goods |
| Hindustan Petroleum Corporation Ltd. | 402.65 | |
Crude Oil |
| Steel Authority Of India Ltd. | 179.58 | |
Iron & Steel |
| Godfrey Phillips India Ltd. | 2249.00 | |
FMCG |
| Hero MotoCorp Ltd. | 5016.40 | |
Automobile & Ancillaries |
| LIC Housing Finance Ltd. | 551.05 | |
Finance |
| Lupin Ltd. | 2272.00 | |
Healthcare |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 24085.7 | 26373.20 | 22182.55 |
| Nifty IT | 28809.55 | 40301.40 | 27078.00 |
| Nifty Next 50 | 72258.5 | 73098.95 | 59896.10 |
| NIFTY50 USD Index | 8832.4 | 10443.40 | 8132.40 |
| Nifty Bank | 57585.05 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 62123.35 | 62907.50 | 52032.85 |
| Nifty 500 | 23109.7 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 17659.65 | 17859.10 | 14804.55 |
| Nifty 100 | 25141.8 | 26975.15 | 22720.45 |
| Nifty FMCG | 49556.05 | 58485.05 | 45334.15 |
Pursuant to Regulation 30 read with Schedule III part A para A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Godfrey Phillips India has informed that it enclosed copy of newspaper publication in Financial Express (English) today, 17th June 2026 informing about the loss of share certificates published pursuant to SEBI circular no. HO/38/13/11(3)2025-MIRSD-POD/I/1102/2025 dated 24th December 2025. The above information shall be made available on the website of the Company www.godfreyphillips.co.in.
The above information is a part of company’s filings submitted to BSE.
Persistent Systems has informed that the Company has made a press release dated June 17, 2026, titled ‘Persistent Celebrates 10 Years of Growth in Mexico, Strengthening Nearshore Capabilities to Advance Enterprise Transformation Across the Americas’. A copy of the Press Release is enclosed.
The above information is a part of company’s filings submitted to BSE.
Glenmark Pharmaceuticals has informed that, Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single‐Dose Vial. Glenmark’s Methylene Blue Injection USP is bioequivalent and therapeutically equivalent to the reference listed drug, ProvayBlue® Injection, 50 mg/10 mL (5 mg/mL), of Provepharm SAS [NDA 204630]. According to IQVIA® sales data for the 12‐month period ending April 2026, the ProvayBlue® Injection, 50 mg/10 mL (5 mg/mL) market achieved annual sales of approximately $19.0 million. The company has attached media release.
3The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of NIFTYMIDCAP index is ₹62123.35 as of 2026-06-17.
The total volume of NIFTYMIDCAP index is 1430646151.00 as of 2026-06-17.
The percentage change in value of NIFTYMIDCAP index is 0.52% as of 2026-06-17.
The absolute increase in NIFTYMIDCAP index value since the previous trading day is ₹321.3 as of 2026-06-17.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
Nifty Midcap 100 stocks are the constituent companies included in the Nifty Midcap 100 Index. These companies generally represent the mid-cap segment of the Indian equity market across multiple sectors.
The Nifty Midcap 100 Index measures the performance of selected mid-sized companies listed on the National Stock Exchange and serves as a benchmark for the mid-cap market segment.
The Nifty Midcap 100 Index comprises 100 constituent stocks selected according to NSE Indices' eligibility criteria, liquidity requirements, and index construction methodology.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.